Fact CheckerSign in

NCT06313710Completed

Head Down Position for Successful Recanalization of Anterior Circulation Large Vessel Occlusion (HOPES4)

Head Down Position for Successful Recanalization of Anterior Circulation Large Vessel Occlusion (HOPES3): a Prospective, Randomized, Open Label, Blinded-end Point, Single-center Study

Source: ClinicalTrials.gov · Last updated 20 Nov 2025

Brief summary (registry, in English)

This is a prospective, randomized, open label, blinded-end point, single-center study, aiming to investigate the effect of head down position in anterior circulation large vessel occlusion patients with successful recanalization after endovascular treatment.

Status (registry)
Completed
Study type
Interventional
Enrollment
90 (actual)
First submitted
5 Mar 2024
Start date
30 Aug 2024
Primary completion date
20 Oct 2025
Lead sponsor
General Hospital of Shenyang Military Region
Diseases
Stroke
NCT number
NCT06313710

What you commit to

  • Study type: Interventional
  • Participants enrolled: 90
  • From 30 Aug 2024 to the primary completion date, 20 Oct 2025
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Hemorrhagic stroke: cerebral hemorrhage, subarachnoid hemorrhage;
  • After recanalization, severe and sustained (i.e., \> 5 minutes) uncontrolled hypertension (systolic blood pressure over 180mmHg or diastolic blood pressure over 105 mmHg) refractory to antihypertensive medication;
  • Cardiac insufficiency (NYHA Class ≥II);
  • The estimated life expectancy is less than 6 months due to other serious diseases;
  • Other conditions unsuitable for this clinical study assessed by researcher.

Lab values

  • Severe hepatic or renal dysfunction, increase in ALT or AST (more than 2 times of upper limit of normal value), increase in serum creatinine (more than 1.5 times of upper limit of normal value) or requiring dialysis;

Other

  • More than four retrieval attempts in the same vessel;
  • Pregnancy, plan to get pregnant or during lactation;

Who the study is looking for

  • Age ≥ 18
  • Anterior circulation large vessel occlusion who received endovascular treatment within 24 hours of stroke onset;
  • National Institute of Health Stroke Scale (NIHSS) ≥ 6 before endovascular treatment;
  • Successful recanalization (mTICI 2b-3) after endovascular treatment;
  • Cerebral circulation time based on DSA of the stroke side was slower than that of the healthy side after successful recanalization;
  • ASPECTS ≥ 6 on CT or DWI;
  • Absence of parenchymal hematoma on CT images done in the angio suite immediately after the procedure;
  • Modified Rankin Scale score before stroke onset ≤ 1;
  • Signed informed consent by patient or their legally authorized representative.

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Department of Neurology, General Hospital of Northern Theater Command
Coordinator of this site? Confirm its status
ShenyangChinaUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.